Mamoru Suzuki

Title: Mamoru Suzuki: Innovator in Immunomodulation

Introduction

Mamoru Suzuki is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunomodulatory compounds. His work has implications for the treatment of various autoimmune diseases.

Latest Patents

Mamoru Suzuki holds a patent for an imidazoline derivative. This compound is characterized by the formula: ##STR1##, wherein R is a halogenophenyl group or a pyridyl group, and X¹ and X² are a hydrogen atom or a lower alkoxy group, or a pharmaceutically acceptable salt thereof. This invention is useful as an immunomodulator and serves as an agent for the treatment and/or prophylaxis of rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, rheumatic fever, and similar conditions. The patent also includes a process for the preparation of this compound and a pharmaceutical composition containing it as an active ingredient.

Career Highlights

Mamoru Suzuki is associated with Tanabe Seiyaku Company, Limited, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Mamoru Suzuki has worked alongside notable colleagues such as Yoshio Iwasawa and Isao Takata. Their collaborative efforts have furthered research in the field of immunomodulation.

Conclusion

Mamoru Suzuki's contributions to the field of immunomodulation through his patented imidazoline derivative highlight his role as an influential inventor. His work continues to impact the treatment of autoimmune diseases, showcasing the importance of innovation in healthcare.